Vident Advisory’s Madison Square Garden MSGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$555K Sell
1,382
-86
-6% -$30.5K ﹤0.01% 1310
2026
Q1
$472K Buy
1,468
+300
+26% +$89.4K ﹤0.01% 1289
2025
Q4
$302K Sell
1,168
-266
-19% -$60.5K ﹤0.01% 1373
2025
Q3
$326K Buy
1,434
+8
+0.6% +$1.64K ﹤0.01% 1367
2025
Q2
$298K Buy
1,426
+47
+3% +$9.05K ﹤0.01% 1307
2025
Q1
$269K Buy
+1,379
New +$285K ﹤0.01% 1317
2024
Q4
– Sell
-995
Closed -$207K – 1512
2024
Q3
$207K Buy
+995
New +$200K 0.01% 1307

Other funds holding MSGS

Vident Advisory's MSGS Position: Q2 2026 in Review

Vident Advisory reduced its Madison Square Garden (MSGS) stake by 5.9% in Q2 2026, selling an estimated $30.5K and leaving 1,382 shares worth $555K. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

Vident Advisory first reported a position in MSGS in Q3 2024 and has held it in 7 quarters since. 469 funds tracked by Wall St. Rank hold MSGS as of Q2 2026.

  • Vident Advisory held 1,382 shares of Madison Square Garden worth $555K as of Q2 2026.
  • Vident Advisory sold 86 Madison Square Garden shares in Q2 2026, an estimated $30.5K.
  • Madison Square Garden made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1310 holding.
  • Vident Advisory first reported a position in Madison Square Garden in Q3 2024 and has held it in 7 quarters since.
  • 469 funds tracked by Wall St. Rank held Madison Square Garden as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.